Our Science
Cephalon science is driven by our commitment to scientific exploration to deliver breakthrough medications to people in need.
Our approach is driven by a dedication to scientific excellence and transparent, data-driven decision making involving scientists at all levels as an integral part of the process.
From the identification of targets, to the optimization of lead molecules to advancing late-stage compounds, Cephalon has developed a robust product portfolio and a diverse pipeline comprised of small molecules, peptides, and biologics addressing a variety of serious illnesses. Projects underway worldwide extend from identifying new compounds to clinical research focused on expanding indications for existing products.
It is not only our scientific expertise and pipeline that have allowed us to grow from a start-up to an internationally recognized biopharmaceutical leader. Our growth and recognition also can be attributed to the flexibility and empowerment of our employees who contribute greatly to the Cephalon R&D efforts. Even though drug discovery and development is dynamic, our culture has been the one constant that has ensured our ability to pursue scientific excellence in the quest for new treatments for disease.